Skip to main content

Table 1 Baseline characteristics of the studied group

From: Effects of two-months balanced diet in metabolically healthy obesity: lipid correlations with gender and BMI-related differences

Variable

MEAN ± DS

Age (years)

42.2 ± 9.5

BMI (Kg/m2)

30.2 ± 3.2

Fat mass (Kg)

33.9 ± 7.0

Free fat mass (kg)

45.8 ± 9.8

Android fat mass (%)

49.7 ± 6.1

apoA1 (g/L)

120.5 ± 25.8

apoB (g/L)

80.9 ± 24.9

Total-Cholesterol (mg/dl)

203.69 ± 37.53

HDL-Cholesterol (mg/dl)

52.64 ± 12.95

LDL-Cholesterol (mg/dl)

128.48 ± 31.8

Triglycerides (mg/dl)

112.87 ± 71.34

Glucose (mg/dl

89.96 ± 9.43

ABSI

6.12 ± 0.42

AIP

0.28 ± 0.27

Leptin (pg/mL)

218.6 ± 165.6

Adiponectin (ng/mL)

83.6 ± 49.6

Leptin/adiponectin

3.4 ± 3.5

GLP-1

1.3 ± 0.5

Grelin (pg/mL)

405.3 ± 253.3

C16:0

27.1 ± 2.6

C16:1

2.8 ± 0.9

C18:0

5.9 ± 0.8

C18:1

22.2 ± 3.6

C18:2 n-6

28.8 ± 4.4

C18:3 n-3

0.5 ± 0.2

C18:3 n-6

0.3 ± 0.2

C20:3 n-6

1.3 ± 0.3

C20:4 n-6

8.7 ± 1.7

C20:5 n-3

0.5 ± 0.3

C22:5 n-3

0.3 ± 0.2

C22:6 n-3

1.6 ± 0.5

AA/EPA

20.3 ± 10.2

Saturated fatty acids

33.1 ± 2.6

Monounsaturated fatty acids

24.9 ± 3.7

Polyunsaturated fatty acids (PUFA)

42 ± 5.02

Total omega-6 PUFA

39.1 ± 5.01

Total omega-3 PUFA

2.9 ± 0.8

omega-6/omega-3

14.3 ± 3.9

  1. Plasma fatty acids are expressed as % of total content
  2. API atherogenic index of plasma, ABSI body shape index, CRP c-reactive protein, GLP-1 glucagon-like peptide-1, HOMA homeostatic model assessment